Michael E. Egger

3.2k citations
134 papers · 2.3k · 1 hit paper · h-index 24

Impact in

  • Oncology top 2%
    • Cutaneous Melanoma Detection and Management
    • CAR-T cell therapy research
    • Pancreatic and Hepatic Oncology Research
    • Cancer Immunotherapy and Biomarkers
  • Hepatology top 5%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • Cutaneous Melanoma Detection and Management 39
    • Pancreatic and Hepatic Oncology Research 7
    • CAR-T cell therapy research 5
    • Hepatocellular Carcinoma Treatment and Prognosis 10

Michael E. Egger

128 papers receiving 2.2k citations

Michael E. Egger's Hit Papers

Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study 2022 · 231 citations
2310+1+2Years since publication50100150200

Peers

Michael E. Egger
Comparison fields: 5 of 108
  • Oncology 1.2k
  • Hepatology 183
  • Cancer Research 208
  • Immunology 219
  • Molecular Biology 485
Replace Christiane Thallinger with:
Christiane Thallinger Austria
Guglielmo Nasti Italy
Soichiro Yokota Japan
Cynthia L. David United States
Chang‐Fang Chiu Taiwan
Ulrich Nitsche Germany
Shiro Oka Japan
Flora Hartveit Norway
Lorraine Cheryl Pelosof United States
Danielle M. Hari United States
Michael E. Egger relative to Christiane Thallinger Austria Christiane Thallinger's profile →
Citations per field
00.5×2×3×4×4.8×
Christiane Thallinger · 1×
Citations per year

Countries citing papers authored by Michael E. Egger

Since Specialization
Citations

This map shows the geographic impact of Michael E. Egger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Egger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Egger more than expected).

Fields of papers citing papers by Michael E. Egger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Egger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Egger. The network helps show where Michael E. Egger may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael E. Egger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael E. Egger Line = papers co-authored together Michael E. Egger links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 134 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study
Hit paper breakdown →
2022231
2 2016154
3 2009137
4 201794
5 201181
6 201654
7 202049
8 201347
9 201337
10 201637
11 201136
12 201234
13 201334
14 201933
15 201831
16 201830
17 201529
18 201529
19 201328
20 201227

About Michael E. Egger

Michael E. Egger is a scholar working on Oncology, Hepatology, Biophysics, Cancer Research and Biotechnology, having authored 134 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (39 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Cell Image Analysis Techniques (7 papers), Pancreatic and Hepatic Oncology Research (7 papers), CAR-T cell therapy research (5 papers), Virus-based gene therapy research (5 papers), Cancer Genomics and Diagnostics (4 papers) and Breast Cancer Treatment Studies (4 papers). The work is most often cited by research in Oncology (1.2k citations), Hepatology (183 citations), Cancer Research (208 citations), Immunology (219 citations) and Molecular Biology (485 citations). Michael E. Egger has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Kelly M. McMasters, Charles Raben Scoggins, Robert C.G. Martin, Arnold J. Stromberg, Prejesh Philips, Glenda G. Callender, Neal Bhutiani, Hongying Hao, Amy R. Quillo and Burkhard Koenig. Their work appears in journals such as Annals of Surgical Oncology, Journal of the American College of Surgeons, The American Journal of Surgery, Surgery and Journal of Surgical Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact